vimarsana.com
Home
Live Updates
UCB : presents new data at 35th International Epilepsy Congr
UCB : presents new data at 35th International Epilepsy Congr
UCB : presents new data at 35th International Epilepsy Congress (IEC) highlighting important advancements across Fintepla▼(fenfluramine) oral solution and broader epilepsies portfolio -Today at 01:04 am
was conducted to examine the efficacy of fenfluramine on GTCS reduction in various types of Developmental and Epileptic Encephalopathies or rare epilepsy conditions. Data from 13 studies , 4...
Related Keywords
Belgium ,
Lingfield ,
Surrey ,
United Kingdom ,
London ,
City Of ,
Brussels ,
Bruxelles Capitale ,
Dublin ,
Ireland ,
Nick Francis ,
Pina Garza ,
Mike Davis ,
Encephalopathies Dees ,
Orrin Devinsky ,
Helen Cross ,
Antje Witte ,
Laurent Schots ,
European Society Of Cardiology ,
Langone Health Comprehensive Epilepsy Center ,
European Respiratory Society ,
International Epilepsy Congress ,
Subgroup Data From The International ,
Corporate Communications ,
Twitter ,
Institute Of Child Health ,
Global Communications ,
Group Of Companies ,
Global Epilepsy ,
Rare Syndromes ,
Epileptic Encephalopathies ,
Professor Helen Cross ,
Childhood Epilepsy ,
Ormond Street Institute ,
Child Health ,
Young Epilepsy ,
Sudden Unexpected Death ,
Comprehensive Epilepsy Center ,
Early Seizure ,
Seizure Termination ,
European Summary ,
Product Characteristics ,
Safety Information ,
Euronext Brussels ,
Accessed August ,
Generalized Tonic Clonic Seizures ,
Rare Epilepsy Syndromes ,
Adult Patients ,
Dravet Syndrome Enrolled De Novo ,
Open Label Extension ,
Drop Seizure Frequency ,
Dose Capped Patients With Lennox Gastaut Syndrome ,
Comparative Analysis ,
Clinical Trial ,
Month Effectiveness ,
Patients With Epilepsy Stratified ,
Subgroup Data From ,
Seizure Termination Project ,
Expert Consensus Recommendations ,
Rapid Termination ,
Subjects With ,
Disorder Followed ,
Markets ,